BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND MUTYH, MYH, 4595, ENSG00000132781, hMYH, MGC4416, MYHbeta
65 results:

  • 1. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan.
    Cheng SM; Su YY; Chiang NJ; Wang CJ; Chao YJ; Huang CJ; Tsai HJ; Chen SH; Chang CY; Tsai CR; Li YJ; Yen CJ; Chuang SC; Chang JS; Shan YS; Hwang DY; Chen LT
    J Biomed Sci; 2024 Feb; 31(1):21. PubMed ID: 38350919
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian cancer (HBOC) by next-generation sequencing.
    Tuncer SB; Celik B; Erciyas SK; Erdogan OS; Gültaslar BK; Odemis DA; Avsar M; Sen F; Saip PM; Yazici H
    Pathol Res Pract; 2024 Feb; 254():155075. PubMed ID: 38219492
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms.
    Venizelos A; Sorbye H; Elvebakken H; Perren A; Lothe IMB; Couvelard A; Hjortland GO; Sundlöv A; Svensson J; Garresori H; Kersten C; Hofsli E; Detlefsen S; Vestermark LW; Ladekarl M; Tabaksblat EM; Knappskog S
    Endocr Relat Cancer; 2023 Oct; 30(10):. PubMed ID: 37410378
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Outcomes of ATA Low-Risk Pediatric Thyroid cancer Patients Not Treated With Radioactive Iodine Therapy.
    Bojarsky M; Baran JA; Halada S; Isaza A; Zhuang H; States L; Grant FD; Robbins S; Sisko L; Ricarte-Filho JC; Kazahaya K; Adzick NS; Mostoufi-Moab S; Bauer AJ
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3338-3344. PubMed ID: 37265226
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. DNA Repair Pathway in Ovarian cancer Patients Treated with HIPEC.
    Flasarova D; Urban K; Strouhal O; Klos D; Lemstrova R; Dvorak P; Soucek P; Mohelnikova-Duchonova B
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240218
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High-grade serous ovarian carcinoma with a sertoliform pattern associated with BRCA mutation: a clinicopathological and molecular analysis.
    Travaglino A; Santoro A; Arciuolo D; Raffone A; Scaglione G; D'Alessandris N; Valente M; Sfregola S; Fulgione C; Onori ME; Minucci A; Zannoni GF
    Virchows Arch; 2023 Dec; 483(6):879-883. PubMed ID: 37166561
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception.
    Bychkovsky BL; Lo MT; Yussuf A; Horton C; Hemyari P; LaDuca H; Garber JE; Scheib R; Rana HQ
    Breast Cancer Res Treat; 2023 Jul; 200(1):63-72. PubMed ID: 36856935
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Increased Risk of Hereditary Prostate cancer in Italian Families with Hereditary Breast and Ovarian cancer Syndrome Harboring Mutations in
    D'Elia G; Caliendo G; Tzioni MM; Albanese L; Passariello L; Molinari AM; Vietri MT
    Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292577
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Low BRCA1 and BRCA2 Germline Mutation Rates in a French-Canadian Population with a Diagnosis of Epithelial Tubo-Ovarian Carcinoma.
    Bernard J; Mehros W; Gregoire J; Douville P; Renaud MC; Sebastianelli A; Langlais EL; Plante M
    J Obstet Gynaecol Can; 2022 Oct; 44(10):1047-1053. PubMed ID: 35779836
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Whole-genome and transcriptome analysis of advanced adrenocortical cancer highlights multiple alterations affecting epigenome and DNA repair pathways.
    Lavoie JM; Csizmok V; Williamson LM; Culibrk L; Wang G; Marra MA; Laskin J; Jones SJM; Renouf DJ; Kollmannsberger CK
    Cold Spring Harb Mol Case Stud; 2022 Apr; 8(3):. PubMed ID: 35483882
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma.
    Manning-Geist B; Gordhandas S; Liu YL; Zhou Q; Iasonos A; Da Cruz Paula A; Mandelker D; Long Roche K; Zivanovic O; Maio A; Kemel Y; Chi DS; O'Cearbhaill RE; Aghajanian C; Weigelt B; Chui MH; Grisham RN
    Clin Cancer Res; 2022 Oct; 28(20):4456-4465. PubMed ID: 35443055
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Emerging Role of Oxidative Stress on EGFR and OGG1-BER Cross-Regulation: Implications in Thyroid Physiopathology.
    Moscatello C; Di Marcantonio MC; Savino L; D'Amico E; Spacco G; Simeone P; Lanuti P; Muraro R; Mincione G; Cotellese R; Aceto GM
    Cells; 2022 Feb; 11(5):. PubMed ID: 35269445
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pancreatic neuroendocrine neoplasms: Updates on genomic changes in inherited tumour syndromes and sporadic tumours based on WHO classification.
    Ishida H; Lam AK
    Crit Rev Oncol Hematol; 2022 Apr; 172():103648. PubMed ID: 35248713
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Current Status of Metastatic Cardiophrenic Lymph Nodes (CPLNs) in Patients With Ovarian cancer: A Review.
    Acs M; Piso P; Prader S
    Anticancer Res; 2022 Jan; 42(1):13-24. PubMed ID: 34969704
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge.
    Bono M; Fanale D; Incorvaia L; Cancelliere D; Fiorino A; Calò V; Dimino A; Filorizzo C; Corsini LR; Brando C; Madonia G; Cucinella A; Scalia R; Barraco N; Guadagni F; Pedone E; Badalamenti G; Russo A; Bazan V
    ESMO Open; 2021 Aug; 6(4):100235. PubMed ID: 34371384
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Forty-eight-year-old female mutyh carrier presenting with five concurrent primary cancers.
    Arroyave A; Nodit L; Clegg D; Russ A
    Cancer Rep (Hoboken); 2022 Feb; 5(2):e1455. PubMed ID: 34173730
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8.
    Paulsson JO; Rafati N; DiLorenzo S; Chen Y; Haglund F; Zedenius J; Juhlin CC
    J Clin Endocrinol Metab; 2021 Oct; 106(11):3265-3282. PubMed ID: 34171097
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. 'You cannot expect miracles to happen overnight': patience pays off when you wish to establish a new adrenocortical carcinoma cell line.
    Lalli E
    Eur J Endocrinol; 2021 Jul; 185(2):C9-C11. PubMed ID: 34096882
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical Contribution of Next-Generation Sequencing Multigene Panel Testing for BRCA Negative High-Risk Patients With Breast cancer.
    Ece Solmaz A; Yeniay L; Gökmen E; Zekioğlu O; Haydaroğlu A; Bilgen I; Özkınay F; Onay H
    Clin Breast Cancer; 2021 Dec; 21(6):e647-e653. PubMed ID: 33980423
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A novel patient-derived cell line of adrenocortical carcinoma shows a pathogenic role of germline mutyh mutation and high tumour mutational burden.
    Landwehr LS; Schreiner J; Appenzeller S; Kircher S; Herterich S; Sbiera S; Fassnacht M; Kroiss M; Weigand I
    Eur J Endocrinol; 2021 May; 184(6):823-835. PubMed ID: 33830941
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.